An Evaluation of the Effectiveness and Tolerability of Tapentadol Hydrochloride Prolonged Release, and Tapentadol Hydrochloride Immediate Release on Demand, in Subjects With Uncontrolled Severe Chronic Nociceptive, Mixed or Neuropathic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics.
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2016
At a glance
- Drugs Tapentadol (Primary) ; Tapentadol (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal
- 03 Jul 2012 New source identified and integrated: European Clinical Trials Database record 2009-010427-12.
- 16 Apr 2012 Actual patient number is 208 according to ClinicalTrials.gov.
- 19 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History